Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma
Eric A. Hungate; Mark A. Applebaum; Andrew D. Skol; Zalman Vaksman; Maura Diamond; Lee McDaniel; Samuel L. Volchenboum; Barbara E. Stranger; John M. Maris; Sharon J. Diskin; Kenan Onel; Susan L. Cohn
Author Information: Section of Hematology/Oncology, Department of Pediatrics (EAH, MAA, ADS, SLV, SLC), Section of Genetic Medicine, Department of Medicine (BES), and Institute for Genomics and Systems Biology, Center for Data Intensive Science (BES), University of Chicago, Chicago, IL; Division of Oncology and Center for Childhood Cancer Research and Department of Biomedical and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA (ZV, MD, LM, JMM, SJD); Department of Pediatrics and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA (JMM, SJD); Department of Pediatrics, Hofstra-Northwell School of Medicine and The Feinstein Institute for Medical Research, Manhasset, NY (KO).
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.